益生菌作为牛皮的辅助疗法的作用
Isadora O Gilli1, Gabriela C da Silva1, Victoria Mendes1
1Clinical Dermatology, Department of Dermatology, Mackenzie Evangelical University Hospital, Curitiba, Brazil.
Journal of psoriasis and psoriatic arthritis
|September 19, 2024
概括
乳杆菌rhamnosus益生菌改善了牛皮的症状和生活质量得分,但没有影响IL-17或IL-23水平. 这种辅助疗法报告的副作用最小.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 像牛皮这样的慢性炎症疾病越来越多地用非传统疗法来治疗.
- 益生菌正在成为炎症状况的重要辅助疗法.
研究的目的:
- 评估 Lactobacillus rhamnosus 补充剂在患有常见和棕植物性牛皮的患者中的疗效.
- 评估对临床评分和特定炎症标志物的影响.
主要方法:
- 一项随机对照试验涉及35名牛皮患者,分为益生菌和安慰剂组.
- 评估包括摄影损伤评估,IL-17和IL-23量化,牛皮重度指数 (PASI),身体表面积 (BSA) 和皮肤病生命质量指数 (DLQI) 在基线和60天的得分.
主要成果:
- 益生菌组的临床表现显著改善,PASI,BSA和DLQI得分有所降低.
- 在益生菌组中没有观察到血清IL-23和IL-17水平的显著降低.
- 与益生菌使用相关的不良事件是最小的.
结论:
- 牛皮菌补充剂与牛皮患者的临床改善有积极的相关性.
- 观察到的治疗益处与IL-17和IL-23水平的降低无关.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Drugs for Treatment of Ulcerative Colitis in IBD
129
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
129
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98


